NM_005422.4:c.2657A>G

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting

The NM_005422.4(TECTA):​c.2657A>G​(p.Asn886Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000814 in 1,612,962 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00060 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00084 ( 1 hom. )

Consequence

TECTA
NM_005422.4 missense

Scores

2
6
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:7B:1

Conservation

PhyloP100: 9.12

Publications

9 publications found
Variant links:
Genes affected
TECTA (HGNC:11720): (tectorin alpha) The tectorial membrane is an extracellular matrix of the inner ear that contacts the stereocilia bundles of specialized sensory hair cells. Sound induces movement of these hair cells relative to the tectorial membrane, deflects the stereocilia, and leads to fluctuations in hair-cell membrane potential, transducing sound into electrical signals. Alpha-tectorin is one of the major noncollagenous components of the tectorial membrane. Mutations in the TECTA gene have been shown to be responsible for autosomal dominant nonsyndromic hearing impairment and a recessive form of sensorineural pre-lingual non-syndromic deafness. [provided by RefSeq, Jul 2008]
TBCEL-TECTA (HGNC:54857): (TBCEL-TECTA readthrough) Predicted to enable alpha-tubulin binding activity. Predicted to be involved in microtubule cytoskeleton organization; post-chaperonin tubulin folding pathway; and tubulin complex assembly. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07219997).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000604 (92/152298) while in subpopulation NFE AF = 0.000956 (65/68022). AF 95% confidence interval is 0.000769. There are 0 homozygotes in GnomAd4. There are 36 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005422.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TECTA
NM_005422.4
MANE Select
c.2657A>Gp.Asn886Ser
missense
Exon 10 of 24NP_005413.2O75443
TBCEL-TECTA
NM_001378761.1
c.3614A>Gp.Asn1205Ser
missense
Exon 16 of 30NP_001365690.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TECTA
ENST00000392793.6
TSL:5 MANE Select
c.2657A>Gp.Asn886Ser
missense
Exon 10 of 24ENSP00000376543.1O75443
TECTA
ENST00000264037.2
TSL:1
c.2657A>Gp.Asn886Ser
missense
Exon 9 of 23ENSP00000264037.2O75443
TECTA
ENST00000642222.1
c.2657A>Gp.Asn886Ser
missense
Exon 10 of 24ENSP00000493855.1A0A2R8YDL0

Frequencies

GnomAD3 genomes
AF:
0.000605
AC:
92
AN:
152178
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000314
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000955
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000475
AC:
119
AN:
250476
AF XY:
0.000436
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000376
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000418
Gnomad NFE exome
AF:
0.000821
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.000836
AC:
1221
AN:
1460664
Hom.:
1
Cov.:
31
AF XY:
0.000807
AC XY:
586
AN XY:
726478
show subpopulations
African (AFR)
AF:
0.000120
AC:
4
AN:
33470
American (AMR)
AF:
0.000515
AC:
23
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26020
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39684
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86126
European-Finnish (FIN)
AF:
0.000393
AC:
21
AN:
53372
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
0.000997
AC:
1108
AN:
1111178
Other (OTH)
AF:
0.00103
AC:
62
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
87
174
260
347
434
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000604
AC:
92
AN:
152298
Hom.:
0
Cov.:
33
AF XY:
0.000483
AC XY:
36
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.000313
AC:
13
AN:
41556
American (AMR)
AF:
0.000654
AC:
10
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000956
AC:
65
AN:
68022
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000760
Hom.:
0
Bravo
AF:
0.000525
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000582
AC:
5
ExAC
AF:
0.000395
AC:
48
EpiCase
AF:
0.000709
EpiControl
AF:
0.00107

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
1
not provided (3)
-
2
-
Autosomal recessive nonsyndromic hearing loss 21 (2)
-
1
-
Autosomal dominant nonsyndromic hearing loss 12 (1)
-
1
-
Autosomal dominant nonsyndromic hearing loss 12;C1863655:Autosomal recessive nonsyndromic hearing loss 21 (1)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.42
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.13
T
Eigen
Uncertain
0.56
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.92
D
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.072
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
9.1
PrimateAI
Uncertain
0.78
T
PROVEAN
Benign
-0.77
N
REVEL
Benign
0.23
Sift
Benign
0.23
T
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.80
MVP
0.74
MPC
0.85
ClinPred
0.080
T
GERP RS
5.7
PromoterAI
-0.015
Neutral
Varity_R
0.13
gMVP
0.59
Mutation Taster
=52/48
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146175803; hg19: chr11-121000636; COSMIC: COSV50713002; COSMIC: COSV50713002; API